{"id":1290,"date":"2026-05-27T15:14:00","date_gmt":"2026-05-27T14:14:00","guid":{"rendered":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/?page_id=1290"},"modified":"2026-05-27T15:25:16","modified_gmt":"2026-05-27T14:25:16","slug":"webinars","status":"publish","type":"page","link":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/webinars\/","title":{"rendered":"Webinars"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Programme&nbsp;for 2025\/2026<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Series of stand-alone webinars developed and delivered by LILLY, with local involvement from NHS Specialists will run from September 2025&nbsp;through to June 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These webinars are non-promotional and will cover a variety of topics. The intended audience is GPs, Practice Nurses and Practice based Pharmacists in Primary Care, however they are open to anyone caring for patients with diabetes.\u200b<\/p>\n\n\n<div class=\"gb-container gb-container-f3ed6e9d\">\n\n<div class=\"wp-block-group is-vertical is-content-justification-center is-layout-flex wp-container-core-group-is-layout-f9faaab3 wp-block-group-is-layout-flex\">\n<h2 class=\"wp-block-heading\">Modular Rolling Programme<\/h2>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">All sessions will be&nbsp;<strong>12.30-1.30<\/strong>&nbsp;and you may register for as many as you like.<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Tuesday 2nd September 2025<\/strong><br>\u2018Identifying risk,&nbsp;ongoing monitoring &amp; standard care processes for adults with Type 2 Diabetes\u2019 <br><em><strong>Please note this session will be held at 12pm-1pm<\/strong><\/em><\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Tuesday 4th November 2025<\/strong><br>\u2018The Self-Care Challenge; supporting people with long term conditions\u2019<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Wednesday 17th December 2025<\/strong><br>\u2018Therapy Choices for adults with Type 2 Diabetes (Part A)\u2019<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Tuesday 20th January 2026<\/strong><br>\u2018Therapy Choices for adults with Type 2 Diabetes (Part B)\u2019<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Tuesday 3rd February 2026<\/strong><br>\u2018Younger Adults with Type 2 Diabetes\u2019<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Tuesday 24th March 2026<\/strong><br>\u2018Understanding Incretin Hormones &amp; their role in the management of adults with Type 2 Diabetes\u2019<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Wednesday 29th April 2026<\/strong><br>\u2018Why Weight Matters in Type 2 Diabetes\u2019<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Wednesday 10th June 2026<\/strong><br>Nutritional Aspects of GLP-1 management<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">To register contact: <a href=\"mailto:loth.diabetesmcneducation@nhs.scot\" target=\"_blank\" rel=\"noreferrer noopener\">loth.diabetesmcneducation@nhs.scot<\/a><\/p>\n<\/div>\n\n<\/div>\n\n<div class=\"gb-container gb-container-ed2ff58c\">\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p class=\"wp-block-paragraph\"><strong>Learning Outcomes<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tuesday 2nd September 2025 \u2018Identifying risk,&nbsp;ongoing monitoring &amp; standard care processes for adults with Type 2 Diabetes\u2019<\/strong> <em>Please note this session will be held at 12pm-1pm<\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>To be confident in identifying those people who are at risk of type 2 diabetes<\/li>\n\n\n\n<li>To be confident in determining an accurate diagnosis of type 2 diabetes<\/li>\n\n\n\n<li>To be aware of the standards of care for type 2 diabetes<\/li>\n\n\n\n<li>To identify the various methods required for the monitoring of type 2 diabetes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tuesday 4th November 2025 \u2018<strong>The Self-Care Challenge; supporting people with long term conditions<\/strong>\u2019<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>To understand how adopting a patient-centered approach can support people with effective self-management and change<\/li>\n\n\n\n<li>To explore the potential conversational structure, language, and tools that promote motivation, self-management and change<\/li>\n\n\n\n<li>To understand the Stages of Change model<\/li>\n\n\n\n<li>To reflect on the best way to support patients with long-term conditions<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Wednesday 17th December 2025 \u2018<strong>Therapy Choices for adults with Type 2 Diabetes (Part A)<\/strong>\u2019<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes<\/li>\n\n\n\n<li>Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs<\/li>\n\n\n\n<li>Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease<\/li>\n\n\n\n<li>Recognise the need to consider therapy specific factors and the individual patient\u2019s circumstances when choosing between different oral therapies<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tuesday<\/strong> <strong>20<sup>th<\/sup> January 2026<\/strong> <strong>\u2018Therapy Choices for adults with Type 2 Diabetes (Part B)\u2019<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes<\/li>\n\n\n\n<li>Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs<\/li>\n\n\n\n<li>Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease<\/li>\n\n\n\n<li>Recognise the need to consider therapy specific factors and the individual patient\u2019s circumstances when choosing between different oral therapies<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tuesday<\/strong> <strong>3<sup>rd<\/sup> February 2026 \u2018Younger Adults with Type 2 Diabetes\u2019<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The growing problem of type 2 diabetes (T2D) in younger adults<\/li>\n\n\n\n<li>The importance of early identification and management<\/li>\n\n\n\n<li>Psychosocial considerations in younger adults with T2D<\/li>\n\n\n\n<li>Holistic approach to care in younger adults with T2D<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tuesday<\/strong> <strong>24<sup>th<\/sup> March 2026 \u2018Understanding Incretin Hormones &amp; their role in the management of adults with Type 2 Diabetes\u2019<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>To understand the role of the incretin hormones, native GLP-1 and GIP, in humans<\/li>\n\n\n\n<li>To discuss the effects of incretin-based therapy in people with T2D and its position in the treatment pathway<\/li>\n\n\n\n<li>To review important considerations of risk management in diabetes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Wednesday<\/strong> <strong>29<sup>th<\/sup> April 2026<\/strong> <strong>\u2018Why Weight Matters in Type 2 Diabetes\u2019<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>To understand the links between weight &amp; Type 2 diabetes and the impact of Type 2 Diabetes on people living with overweight\/obesity<\/li>\n\n\n\n<li>To review the pathophysiology of Type 2 diabetes in people living with overweight and obesity<\/li>\n\n\n\n<li>To recognise the importance and challenges of weight management in people with Type 2 Diabetes<\/li>\n\n\n\n<li>To explore ways to support people in achieving their treatment and weight management goals<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Wednesday<\/strong> <strong>10<sup>th<\/sup> June 2026<\/strong> <em><strong>(TBC)<\/strong><\/em><\/p>\n<\/div><\/div>\n\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><\/h2>\n\n\n\n<h2 class=\"wp-block-heading\"><\/h2>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-left\">Programme\u00a0for 2026\/2027<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Series of stand-alone webinars developed and delivered by LILLY, with local involvement from NHS Specialists will run from September 2026\u00a0through to March 2027.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These webinars are non-promotional and will cover a variety of topics. The intended audience is GPs, Practice Nurses and Practice based Pharmacists in Primary Care, however they are open to anyone caring for patients with diabetes.\u200b<\/p>\n\n\n\n<div class=\"wp-block-group has-light-accent-grey-background-color has-background is-vertical is-content-justification-center is-layout-flex wp-container-core-group-is-layout-f9faaab3 wp-block-group-is-layout-flex\">\n<h2 class=\"wp-block-heading\">Modular Rolling Programme<\/h2>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">All sessions will be&nbsp;<strong>12.30-1.30<\/strong>&nbsp;and you may register for as many as you like.<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong>Wednesday 2nd September 2026<\/strong><br>Identifying risk,\u00a0ongoing monitoring &amp; standard care processes for adults with Type 2 Diabetes <\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong><strong>Wednesday 7th October 2026<\/strong><\/strong><br>Why Weight Matters in Type 2 Diabetes<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong><strong><strong><strong>Wednesday 4th November 202<\/strong>7<\/strong><\/strong><\/strong><br>Younger Adults with Type 2 Diabetes<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong><strong>Wednesday 13th January 202<\/strong>7<\/strong><br>Therapy Choices for adults with Type 2 Diabetes <\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong><strong><strong>Wednesday 10th February 202<\/strong>7<\/strong><\/strong><br>Nutritional Aspects of GLP-1 management<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong><strong><strong>Wednesday 10th March 202<\/strong>7<\/strong><\/strong><br>F2F Event GLP-1 practical management\/case<br>studies\/prescribing workshop<\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">To register contact: <a href=\"mailto:loth.diabetesmcneducation@nhs.scot\" target=\"_blank\" rel=\"noreferrer noopener\">loth.diabetesmcneducation@nhs.scot<\/a><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group has-light-accent-grey-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p class=\"wp-block-paragraph\"><strong>Learning Outcomes<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>T<strong>Wednesday 2nd September 2026<\/strong><\/strong> <strong>Identifying risk,\u00a0ongoing monitoring &amp; standard care processes for adults with Type 2 Diabetes<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>To be confident in identifying those people who are at risk of type 2 diabetes<\/li>\n\n\n\n<li>To be confident in determining an accurate diagnosis of type 2 diabetes<\/li>\n\n\n\n<li>To be aware of the standards of care for type 2 diabetes<\/li>\n\n\n\n<li>To identify the various methods required for the monitoring of type 2 diabetes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><strong><strong>Wednesday 7th October 2026<\/strong><\/strong> <\/strong> <strong>Why Weight Matters in Type 2 Diabetes<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>To understand the links between weight &amp; Type 2 diabetes and the impact of Type 2 Diabetes on people living with overweight\/obesity<\/li>\n\n\n\n<li>To review the pathophysiology of Type 2 diabetes in people living with overweight and obesity<\/li>\n\n\n\n<li>To recognise the importance and challenges of weight management in people with Type 2 Diabetes<\/li>\n\n\n\n<li>To explore ways to support people in achieving their treatment and weight management goals<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><strong><strong>Wednesday 4th Novembver202<\/strong>7<\/strong> Younger Adults with Type 2 Diabetes<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The growing problem of type 2 diabetes (T2D) in younger adults<\/li>\n\n\n\n<li>The importance of early identification and management<\/li>\n\n\n\n<li>Psychosocial considerations in younger adults with T2D<\/li>\n\n\n\n<li>Holistic approach to care in younger adults with T2D<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><strong>Wednesday 13th January 202<\/strong>7<\/strong> <strong>Therapy Choices for adults with Type 2 Diabetes <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes<\/li>\n\n\n\n<li>Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs<\/li>\n\n\n\n<li>Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease<\/li>\n\n\n\n<li>Recognise the need to consider therapy specific factors and the individual patient\u2019s circumstances when choosing between different oral therapies<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><strong><strong>Wednesday 10th February 202<\/strong>7<\/strong> Nutritional Aspects of GLP-1 management<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Identify malnutrition risk factors and basic nutrition guidelines for patients prescribed incretin therapies<\/li>\n\n\n\n<li>Understand the impact of dietary intake and physical activity on body composition during treatment with incretin therapy<\/li>\n\n\n\n<li>Evaluate the importance of nutrient \u2013 dense diets alongside incretin therapies<\/li>\n\n\n\n<li>Discuss common nutrition concerns associated with using incretin therapies to manage metabolic disease<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><strong><strong>Wednesday 10th March 202<\/strong>7<\/strong><\/strong> <strong>F2F Event GLP-1 practical management\/case studies\/prescribing workshop<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>F2F Event GLP-1 practical management\/case studies\/prescribing workshop<\/li>\n<\/ul>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Programme&nbsp;for 2025\/2026 Series of stand-alone webinars developed and delivered by LILLY, with local involvement from NHS Specialists will run from September 2025&nbsp;through to June 2026. These webinars are non-promotional and<\/p>\n","protected":false},"author":27,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/fullwidth.php","meta":{"_searchwp_excluded":"","footnotes":""},"categories":[],"class_list":["post-1290","page","type-page","status-publish","hentry"],"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"scottsamson","author_link":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/author\/scottsamson\/"},"rttpg_comment":0,"rttpg_category":false,"rttpg_excerpt":"Programme&nbsp;for 2025\/2026 Series of stand-alone webinars developed and delivered by LILLY, with local involvement from NHS Specialists will run from September 2025&nbsp;through to June 2026. These webinars are non-promotional and","_links":{"self":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages\/1290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/comments?post=1290"}],"version-history":[{"count":11,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages\/1290\/revisions"}],"predecessor-version":[{"id":1822,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/pages\/1290\/revisions\/1822"}],"wp:attachment":[{"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/media?parent=1290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staff.nhslothian.scot\/diabetesprofessionaleducation\/wp-json\/wp\/v2\/categories?post=1290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}